Room-temperature consolidated calcium phosphate bioceramics as drug delivery systems
Bioceramic vehicles for localized drug delivery are well established, but the ceramic sintering temperatures limit the means of drug incorporation and surface-bound drugs are often released rapidly into the surrounding environment. Room-temperature consolidation (RTC) opens a possibility to create bioceramic drug delivery systems, where the drug is distributed within the entire volume of the carrier, potentially achieving higher control over the release profile. In this study, strontium ranelate (SR) containing nanocrystalline hydroxyapatite (nHAp), amorphous calcium phosphate (ACP) and octacalcium phosphate (OCP) bioceramics were produced, using RTC. The low-temperature, high-pressure approach preserved the metastable, low-crystalline calcium phosphates, but minor pressure-induced deterioration of the drug’s ranelic acid residue was present. Ultimately, by varying the consolidation pressure, drug content and calcium phosphate matrix, drug delivery lasting from three to 58 days was achieved.
Authors
- Gints Ernestsons
- Jānis Ločs (ORCID: https://orcid.org/0000-0003-3162-7431)
- Gustavs Eduards Ernestsons
- Linda Dauge
Institutions
- Riga Technical University (LV)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-80776-8
- Primary Topic
- Bone Tissue Engineering Materials
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- European Regional Development Fund